BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 9710674)

  • 1. Enterococci and vancomycin resistance.
    French GL
    Clin Infect Dis; 1998 Aug; 27 Suppl 1():S75-83. PubMed ID: 9710674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidrug-resistant gram-positive pathogens. An update on current microbiological patterns.
    Marchese A; Debbia EA; Bacca D; Balistreri G; Musolino B; Schito GC
    Drugs; 1997; 54 Suppl 6():11-20. PubMed ID: 9474477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycopeptide-resistant enterococci: a decade of experience.
    Woodford N
    J Med Microbiol; 1998 Oct; 47(10):849-62. PubMed ID: 9788808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vancomycin-resistant enterococci: why are they here, and where do they come from?
    Bonten MJ; Willems R; Weinstein RA
    Lancet Infect Dis; 2001 Dec; 1(5):314-25. PubMed ID: 11871804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Avoparcin, a glycopeptide used in animal foods: antimicrobial spectrum and potency tested against human isolates from the United States.
    Cormican MG; Erwin ME; Jones RN
    Diagn Microbiol Infect Dis; 1997 Dec; 29(4):241-8. PubMed ID: 9458981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human infections caused by glycopeptide-resistant Enterococcus spp: are they a zoonosis?
    Sundsfjord A; Simonsen GS; Courvalin P
    Clin Microbiol Infect; 2001; 7 Suppl 4():16-33. PubMed ID: 11688531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The specter of glycopeptide resistance: current trends and future considerations.
    Moellering RC
    Am J Med; 1998 May; 104(5A):3S-6S. PubMed ID: 9684651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should genotypic testing be done on all phenotypically vancomycin- resistant enterococci detected in hospitals?
    Coombs GW; Kay ID; Steven RA; Pearman JW; Bertolatti D; Grubb WB
    J Clin Microbiol; 1999 Apr; 37(4):1229-30. PubMed ID: 10215453
    [No Abstract]   [Full Text] [Related]  

  • 9. Glycopeptide resistance in enterococci.
    Méndez-Alvarez S; Pérez-Hernández X; Claverie-Martín F
    Int Microbiol; 2000 Jun; 3(2):71-80. PubMed ID: 11001535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of Vancomycin-Resistant Enterococcus Strains in the West Balkans: A First Report.
    Jakovac S; Bojić EF; Ibrišimović MA; Tutiš B; Ostojić M; Hukić M
    Microb Drug Resist; 2017 Jan; 23(1):122-126. PubMed ID: 27351410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The challenge of vancomycin-resistant enterococci: a clinical and epidemiologic study.
    Lam S; Singer C; Tucci V; Morthland VH; Pfaller MA; Isenberg HD
    Am J Infect Control; 1995 Jun; 23(3):170-80. PubMed ID: 7677262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycopeptide-resistance transferability from vancomycin-resistant enterococci of human and animal source to Listeria spp.
    de Niederhäusern S; Sabia C; Messi P; Guerrieri E; Manicardi G; Bondi M
    Lett Appl Microbiol; 2004; 39(6):483-9. PubMed ID: 15548299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vancomycin-resistant enterococci.
    Moellering RC
    Clin Infect Dis; 1998 May; 26(5):1196-9. PubMed ID: 9597252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro antibacterial activity of LY333328, a new semisynthetic glycopeptide.
    Biavasco F; Vignaroli C; Lupidi R; Manso E; Facinelli B; Varaldo PE
    Antimicrob Agents Chemother; 1997 Oct; 41(10):2165-72. PubMed ID: 9333042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activities of the semisynthetic glycopeptide LY191145 against vancomycin-resistant enterococci and other gram-positive bacteria.
    Nicas TI; Mullen DL; Flokowitsch JE; Preston DA; Snyder NJ; Stratford RE; Cooper RD
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2585-7. PubMed ID: 8585753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vancomycin-resistant enterococci (VRE). Recent results and trends in development of antibiotic resistance].
    Klare I; Witte W; Wendt C; Werner G
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 Nov; 55(11-12):1387-400. PubMed ID: 23114437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Glycopeptide-resistant enterococci carriage: Are actual isolation and identification techniques sufficient?].
    Surcouf C; Fabre M; Enouf V; Cadé S; Soler C; Mac Nab C; Samson T; Foissaud V
    Pathol Biol (Paris); 2011 Jun; 59(3):146-50. PubMed ID: 19477606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycopeptide resistance in enterococci.
    Arthur M; Reynolds P; Courvalin P
    Trends Microbiol; 1996 Oct; 4(10):401-7. PubMed ID: 8899966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vancomycin resistance in gram-positive cocci.
    Courvalin P
    Clin Infect Dis; 2006 Jan; 42 Suppl 1():S25-34. PubMed ID: 16323116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spread of vancomycin-resistant enterococci: differences between the United States and Europe.
    Goossens H
    Infect Control Hosp Epidemiol; 1998 Aug; 19(8):546-51. PubMed ID: 9758053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.